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ABSTRACT: Eﬃcient delivery of growth factors is one of the
great challenges of tissue engineering. Polyelectrolyte multi-
layer ﬁlms (PEM) made of biopolymers have recently emerged
as an interesting carrier for delivering recombinant human
bone morphogenetic protein 2 (rhBMP-2 noted here BMP-2)
to cells in a matrix-bound manner. We recently showed that
PEM made of poly(L-lysine) and hyaluronan (PLL/HA) can
retain high and tunable quantities of BMP-2 and can deliver it
to cells to induce their diﬀerentiation in osteoblasts. Here, we
investigate quantitatively by Fourier transform infrared spec-
troscopy (FTIR) the secondary structure of BMP-2 in solution as well as trapped in a biopolymeric thin ﬁlm. We reveal that the
major structural elements of BMP-2 in solution are intramolecular β-sheets and unordered structures as well as α-helices.
Furthermore, we studied the secondary structure of rhBMP-2 trapped in hydrated ﬁlms and in dry ﬁlms since drying is an
important step for future applications of these bioactive ﬁlms onto orthopedic biomaterials. We demonstrate that the structural
elements were preserved when BMP-2 was trapped in the biopolymeric ﬁlm in hydrated conditions and, to a lesser extent, in dry
state. Importantly, its bioactivity was maintained after drying of the ﬁlm. Our results appear highly promising for future
applications of these ﬁlms as coatings of biomedical materials, to deliver bioactive proteins while preserving their bioactivity upon
storage in dry state.
■ INTRODUCTION
Eﬃcient delivery of growth factors is one of the great challenges
of tissue engineering.1 It is now acknowledged that large doses
of potent growth factors, delivered in solution, can lead to
severe side eﬀects.2 Engineered materials that can regulate the
biological presentation of growth factors represent a new class
of therapeutic agents for the treatment of a wide variety of
diseases.3 The ideal carrier would retain and sequester the
growth factor locally, thus reducing the dose needed, while
enhancing its eﬃcacy.4 Importantly, the carrier should preserve
the protein bioactivity, which is directly related to its secondary
and tertiary structure.
The bone morphogenetic protein (BMP) family is an
intensive ﬁeld of research in its own for tissue engineering
applications5 as well as for fundamental cell biology studies6
due to its physiological importance. BMPs play a crucial role in
morphogenesis, tissue patterning and regeneration after tissue
damage.7 In particular, BMP-2 is a highly potent morphogen
that induces muscle precursors and mesenchymal stem cell
diﬀerentiation in bone cells.8 Currently, BMP-2 is used in
clinics,9 and the only approved formulation of BMP-2 uses an
absorbable collagen sponge as a carrier agent. However, up to
12 mg (much higher dose than physiological concentrations) is
used, thus raising serious concerns about its safety as reported
in the recent literature.10 Other carrier biomaterials have been
and are currently being developed.5,11 Mimics of the natural
extracellular matrix, including ﬁbrin ﬁlms,12 hyaluronan hydro-
gels,13 and polypeptide and polysaccharide-based layer-by-layer
ﬁlms14,15 appear particularly interesting due to their natural
composition. Natural biopolymers may not only permit the
protein from being presented in a “matrix-bound” manner, but
they also provide a water-rich environment. This may be a
crucial point for preserving the stability of the proteins in the
dry state once loaded in the biopolymeric coatings. In fact,
dehydration is known to possibly greatly impact proteins
structures.16 The drying process removes part of the hydration
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layer, which may disrupt the native state of a protein and cause
protein aggregation.16 It is known that protein conformation is
very often lost upon storage in dry conditions, unless stabilizers
such as sugars, polyols, or polyaminoacids are added during the
freeze-drying process.16 Very recently, atomistic molecular
dynamics simulations17 suggested that the environment
(vacuum versus water) is a key factor in the stabilization of
the secondary and tertiary structure of BMP-2. Friess and co-
workers have shown that controlled precipitation of BMP-2
proteins from highly concentrated solutions (20 mg/mL) lead
to the formation of microparticles of micrometer size (7 and 35
μm bimodal distribution).18 They used Fourier transform
infrared (FTIR) spectroscopy to show that the structure of
BMP-2 in the precipitated state and after resolubilization in an
acidic buﬀer was similar to that of the protein in solution.19
They evidenced the formation of mainly β-sheet structures and
α-helices. The formation of β-sheets was also observed by
circular dichroism.20
However, quantitative information on BMP-2 secondary
structure in solution or in a carrier material is still lacking. Here,
we quantitatively investigated by FTIR the secondary structure
of BMP-2 in solution as well as trapped in a nanostructured
biopolymeric thin ﬁlm. The ﬁlm is a polyelectrolyte multilayer
ﬁlm made of poly(L-lysine) and hyaluronan (PLL/HA), which
was recently shown to retain high and tunable quantities of
rhBMP-2 and to deliver it to cells in a “matrix-bound”
manner.15,21 FTIR was chosen as it is a powerful technique to
qualitatively and quantitatively assess protein secondary
structure22−24 and to obtain the relative amount of diﬀerent
types of secondary structures based on the band areas.25−27 It is
a very precise (<2 cm−1), sensitive, and reproducible
technique28,29 that is indeed routinely used to assess the
secondary structure of therapeutic proteins.
■ MATERIALS AND METHODS
Materials. PLL hydrobromide (P2626, 6.8 × 104 g/mol) was
purchased from Sigma (St-Quentin Fallavier, France), and HA (3.6 ×
105 g/mol) was obtained from Lifecore Biomedical (USA). They were
dissolved at 0.5 mg/mL and 1 mg/mL, respectively, in a buﬀered
saline (0.15 M NaCl, 20 mM HEPES, pH 7.4, called hereafter HEPES-
NaC l buﬀe r ) . Fo r ﬁ lm c ro s s - l i n k i ng , 1 - e t hy l - 3 - [ 3 -
dimethylaminopropyl]carbodiimide hydrochloride (EDC, Sigma, St
Quentin Fallavier, France) was mixed with a N-hydroxysulfosuccini-
mide (sulfo-NHS, Chemrio, China) in 0.15 M NaCl solution (pH 5.5)
at concentrations of 30 mg/mL and 11 mg/mL, respectively. BMP-2
was from Medtronic Biopharma BV.
Quantitative Analysis by FTIR Spectroscopy. A Vertex 70
spectrophotometer (Bruker Optics Gmbh, Ettlingen, Germany) was
used for the acquisition of FTIR spectra. Single-channel spectra were
recorded between 400 and 4000 cm−1 with a 2 cm−1 resolution by
means of the OPUS Software v6.5 (Bruker). A nitrogen-cooled
mercury−cadmium−telluride (MCT) detector was used to improve
the detection level. Such detector is known to produce a noise level
10−50 times lower than other detectors.29 Diﬀerent accessories were
used depending on the experiments: an Aquaspec transmission cell for
studying BMP-2 in solution, an attenuated total reﬂection (ATR)
liquid cell for the study of BMP-2 loaded in hydrated ﬁlms, and a
standard transmission accessory for the study of the BMP-2 loaded
ﬁlms deposited on silicon substrates and subsequently dried. All these
accessories were purchased from Bruker Optics.
The OPUS Software v6.5 (Bruker GmbH) was used for the
treatment and deconvolution of the spectra. Residual water and CO2
contributions were removed, and baseline correction was done
manually, choosing always the same reference points in each group
of spectra. When residual noise due to water (especially in dry
conditions) was still present, the spectra were smoothened using a
speciﬁc algorithm from Opus software. The frequencies of the diﬀerent
components forming the amide I band were ﬁrst determined by
calculating of the second derivative of the Fourier smoothed
spectrum.25,27 There was thus no arbitrary decomposition into a
preset number of bands and on the peak position. Once the number of
component bands was determined, the amide I band was ﬁtted by
using the component frequency, width, and intensity as ﬁtting
parameters. The more consistent results were obtained when all
component peaks were assumed to be Gaussian. The correspondence
of each component band with a given secondary structure was
established by comparing the frequency of its maximum to the value
given in the literature.30 We deﬁned the relative contribution of each
component (in %) by the ratio of the area of each peak over the area
of the total amide I band.27
Characterization of BMP-2 Secondary Structure in Solution.
First, the BMP-2 solution was puriﬁed. To this end, it was ﬁrst
precipitated using a 10% ammonium sulfate (AS) solution.31 The
mixture was centrifuged at 13000 rpm for 10 min after which the
supernatant was removed. This procedure was repeated three times
with a 2% AS solution. Finally, the protein was resuspended in the 1
mM HCl in D2O (pH = 3) solution or in the HEPES-NaCl buﬀer in
D2O (pH = 7.4). The ﬁnal protein concentration was ∼2 mg/mL for
rhBMP-2 in 1 mM HCl (pH 3). At pH 7.4, the protein is known to be
less soluble.20,32,33 We estimated the BMP-2 concentration of the
resuspended solution to be 400 μg/mL at this pH, based on the
diﬀerence of the maximum absorbance of the protein. Sixty microliters
of BMP-2 was injected in the Aquaspec cell, and a single-channel
spectrum of 64 interferograms was recorded.
PLL/HA Film Characterization by FTIR. The buildup of PLL/
HA ﬁlms in HEPES-NaCl buﬀer was followed by FTIR spectroscopy
as previously described.34 For studies in hydrated conditions, D2O was
used as solvent instead of water in order to avoid the overlapping
water band in the amide I region (O−H bending vibration at 1643
cm−1 versus O−D bending vibration at 1209 cm−1). The spectra of
hydrated (PLL/HA)12 ﬁlms were acquired in situ using ATR mode.
To this end, ﬁlms were built and cross-linked on a ZnSe crystal, and a
single-channel spectrum of 64 interferograms was recorded. For
studies in dry conditions, ﬁlms were built as described previously35 on
a ∼ 1 cm2 silicon substrate (Siltronix, France) using HEPES-NaCl
(dissolved in H2O) followed by cross-linking. The ﬁlms were then
rinsed with milli-Q water to remove the salt and dried for 1 h at 37 °C.
The ﬁlm spectra in transmission were acquired by summing 256
interferograms. For long-term stability measurements, the ﬁlms were
stored in the dry state at 4 °C. Before each FTIR acquisition, they were
incubated for 1 h at 37 °C.
Characterization of BMP-2 Secondary Structure in Hydrated
and in Dry PLL/HA Films. For BMP-2 trapped in hydrated (PLL/
HA)12 ﬁlms built in D2O, BMP-2 was loaded from a solution at 100
μg/mL in 1 mM HCl in D2O (pH = 3) following the protocol
established previously.15 The rinsing steps were done with HEPES-
NaCl buﬀer. The spectrum of BMP-2 was obtained by subtracting the
spectrum of the ﬁlm in contact with the HEPES-NaCl buﬀer to that of
the BMP-2-loaded ﬁlm (measured in the same buﬀer after rinsing of
the ﬁlm).
For study of BMP-2 in dry ﬁlms, BMP-2 in 1 mM HCl (in H2O)
was loaded in the PLL/HA ﬁlm prepared in the HEPES-NaCl buﬀer
(in H2O) and dried as described above for the ﬁlm. The spectrum of
BMP-2 inside dry ﬁlms was obtained by calculating the diﬀerence
between the average spectrum of two independent BMP-2 loaded
ﬁlms and the average spectrum of two control samples (i.e., ﬁlms that
have followed the same procedure, except that BMP-2 was not present
in the loading solution).
C2C12 Cell Culture and Alkaline Phosphatase Activity Test
(ALP Test). Murine C2C12 skeletal myoblasts (<25 passages,
obtained from the American Type Culture Collection, ATCC) were
cultured in tissue culture Petri dishes, in a 1:1 Dulbecco’s modiﬁed
Eagle medium (DMEM)/Ham’s F12 medium (Gibco, Invitrogen,
France) mixture supplemented with 10% fetal bovine serum (FBS,
PAA Laboratories, France), 100 U/mL penicillin G, and 100 μg/mL
streptomycin (Gibco, Invitrogen, France) in a 37 °C, 5% CO2
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incubator. Cells were subcultured prior to reaching 60−70%
conﬂuence (approximately every 2 days).
The bioactivity of BMP-2 on C2C12 cells was determined by
assaying the ALP activity, a marker of osteogenic diﬀerentiation, as
previously described.15 C2C12 cells were seeded in 24-well plates (90
000 cells per well) in 1 mL of growth medium. After 3 days of culture,
the culture medium was removed, and the cells were washed with PBS
and lysed by sonication (5 s) in 500 μL of 0.1% Triton-X100 in PBS.
180 μL of a buﬀer containing 0.1 M 2-amino-2-methyl-L-propanol
(Sigma, France), 1 mM MgCl2, and 9 mM p-nitrophenyl phosphate
(Euromedex, France) adjusted to pH 10 was added to 20 μL of lysate.
The enzymatic reaction was monitored in a 96-well plate by measuring
the absorbance at 405 nm using a TECAN Inﬁnite 1000 microplate
reader (Tecan, Austria) over 10 min. The total protein content of each
sample was determined using a bicinchoninic acid-based protein assay
kit (Interchim, France). The ALP activity was expressed as mmoles of
p-nitrophenol produced per minute per milligram of protein (pnp/
min/mg).
The bioactivity of loaded BMP-2 was also assessed after drying the
ﬁlm and upon storage at 4 °C. To this end, the samples were loaded
with BMP-2 as previously described and thoroughly washed in
HEPES-NaCl buﬀer then in ultrapure water. They were air-dried for 2
h under a laminar ﬂow hood and stored at 4 °C. The BMP-2 activity
was determined right after this drying step and after 1 month of
storage. The samples were rehydrated 30 min in the HEPES-NaCl
buﬀer and sterilized under UV irradiation before depositing cells. The
ALP activity test was performed after 3 days of culture.
■ RESULTS AND DISCUSSION
Secondary Structure of BMP-2 in Solution at Acidic
and at Neutral pH. The secondary structure of BMP-2
protein was ﬁrst investigated by FTIR in solution (Figure 1)
with a focus on the Amide I band. pH 3 was selected as it
corresponds to its maximum solubility36 and to the
recommended conditions of storage. Indeed, we have
previously shown that loading of BMP-2 in the biopolymeric
ﬁlm at pH 3 was optimum in terms of homogeneity and loaded
amount.15 Physiological conditions (0.15 M NaCl, pH 7.4,
Figure 1B), which correspond to the conditions of ﬁlm buildup
and cell culture experiments, were also studied. Second
derivatives of the spectra were also calculated (Figure
1A′,B′). Based on these second derivatives, on FTIR data on
proteins,30 and on a previous study on precipitated BMP-2
microparticles,19 the ﬁve observed minima were attributed to
four diﬀerent types of secondary structures as follows: ∼1630
cm−1 and ∼1680 cm−1 to antiparallel β-sheets (two
contributions at low and high wavenumbers, LW and HW,
respectively), 1645 cm−1 to unordered, ∼1651−1657 cm−1 to
α-helix, and ∼1670 cm−1 to β-turn structures.30
At ﬁrst sight, the spectra of BMP-2 at diﬀerent pHs appeared
to diﬀer as its maximum was positioned at 1645 cm−1 for BMP-
2 at pH 3, whereas it was at 1633 cm−1 for BMP-2 at pH 7.4 in
the presence of salt. Decomposition of the amide I band
allowed the quantiﬁcation of the respective contributions of
each type of secondary structure (Table 1).
Independent experiments indicated that the precision of the
peak position obtained by ﬁtting the spectra is <2 cm−1. The
precision on the % of secondary structures can be estimated at
∼3 to 4% for the most prominent peaks and highest peaks and
∼1−2% for the smallest ones.
Figure 1. FTIR spectra and corresponding second derivatives of rhBMP-2 in solution at pH 3 (A,A′) and at pH 7.4 (B,B′) (black: experimental
spectrum; gray: ﬁtted spectrum). Measurements were performed in D2O.
Table 1. Results of the Deconvolution of the FTIR spectra of rhBMP-2 in Solution at pH 3 (No Salt) or at pH 7.4 (HEPES-
NaCl Buﬀer) as Well as in Hydrated or Dry Polyelectrolyte Multilayer Filmsa
LW inter. β-sheet LW intra. β-sheet unordered α-helix β-turn HW intra. β-sheet HW inter. β-sheet
BMP-2 in solution pH 3 1631 1646 1660 1674 1683 W
39 27 24 7 3 %
BMP-2 in solution Hepes-NaCl pH 7.4 1630 1646 1657 1668 1678 W
44 24 16 9 7 %
BMP-2 trapped in hydrated ﬁlm 1617 1630 1644 1658 1670 1680 1690 W
2 28 31 18 11 8 1 %
BMP-2 trapped in dry ﬁlm 1628 1638 1652 1664 1678 1689 1694 W
2 21 34 21 16 5 1 %
aLW/HW: Low/High Wavenumber; W: Wavenumber (cm−1); %: percentage relative to the total amide I band integral.
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First, we noticed that the highest contribution was that of
antiparallel β-sheets (sum of LW and HW β-sheet), which
accounted for 42% of the structure at pH 3 and 51% at pH 7.4
in the presence of salt. The α-helix contribution represented
24% of the secondary structure at pH 3 and only 16% at pH
7.4. Of note, the percent of unordered structures remained
unchanged (∼ 24−27%) under both conditions, and the
percent of β-turn was also similar (∼ 7−9%). Thus, the
formation of β-sheet structures was induced by the increase of
pH closer to its isoelectric point (8.537), where BMP-2 is less
soluble.32
These experimental determinations of the percent of
secondary structures were indeed relatively close to the values
deduced from the crystal structure of BMP-238 and from
molecular dynamics simulations of BMP-2 structure in water.17
These latter values range from 41 to 52% for β-sheets and from
8 to 12% for α-helix structures. Experimental data obtained by
circular dichroism also indicated the prominence of β-sheets.20
In addition, FTIR data on native BMP-2 at very high
concentration (20 mg/mL) and on dried microparticles of
BMP-2 showed that β-sheets represented ∼25% of the
secondary structural elements.18 Thus, although performed in
diﬀerent experimental conditions, our data are consistent with
these previous experimental and theoretical studies.
Secondary Structure of PLL/HA Films. Next, we
investigated the structure of the polyelectrolyte multilayer
ﬁlm that was used as a reservoir for BMP-2 storage in the
hydrated and dry states. This analysis was important to obtain
information on the possible changes in the ﬁlm structure. We
studied the amide I region in diﬀerent solvents (D2O versus
H2O) and in hydrated or dry conditions.
Figure 2 shows the typical infrared spectra of cross-linked
(PLL/HA)12 ﬁlms in hydrated and dry states with a focus on
the amide I and amide II bands. The spectrum of the hydrated
ﬁlm is shown for ﬁlms built in D2O and in H2O. The spectrum
of dry ﬁlm was obtained after drying a ﬁlm prepared in HEPES-
NaCl buﬀer in H2O.
The comparison between the spectra for hydrated ﬁlms
obtained in D2O and in H2O revealed some diﬀerences. The
most signiﬁcant change was the shift of the entire amide II band
from 1557 cm−1 (maximum of this band) to 1465 cm−1 when
the ﬁlm was built in a D2O. This shift can be justiﬁed by the
hydrogen/deuterium exchange as reported previously in the
literature.39 In (PLL/HA) ﬁlms, the amide I band is mainly
representative of the PLL structure.40 The second derivatives
allow one to determine the position of the major peak of the
amide I band (Figure 2A′). A strong minimum was visible at
1638 cm−1 for the ﬁlm built in D2O, at 1644 cm
−1 for that built
in H2O, and at 1656 cm
−1 for the dry ﬁlm, which could be
attributed to unordered structures.40,41 Thus there was a
signiﬁcant shift toward higher wavenumbers especially for the
dry ﬁlm (+12 cm−1 after drying the ﬁlm built in water). This
total shift is due to the combined eﬀect of solvent exchange and
subsequent drying,39 as the ﬁlm was built in D2O for studies in
hydrated conditions versus H2O for studies on dry and stored
ﬁlms. A weaker contribution, attributed to turn structures, was
observed at 1663 and 1674 cm−1 for hydrated ﬁlms and at 1680
cm−1 for dry ﬁlms. The COO− contribution was also shifted
from ∼1600 cm−1 in H2O to 1607 cm−1 in D2O and ∼1612
cm−1 for dry ﬁlms. A small contribution of COOH of HA was
also visible at ∼1735 cm−1.
After peak decomposition (Supporting Information, Figure
SI1), we found that ∼90−95% of the structural elements in
PLL/HA hydrated or dry ﬁlms were unordered structures and
that only 5−10% were turn structures. We thus conclude that
the hydrated PLL/HA ﬁlm exhibited mostly an unordered
structure, which was maintained after drying the ﬁlm.
Structure of BMP-2 Trapped in Hydrated or Dry PLL/
HA Films. The structure of BMP-2 trapped in hydrated or dry
(PLL/HA) ﬁlms was subsequently investigated (Figure 3). In
this case, some interactions between the protein and the ﬁlm
might occur, as BMP-2 has a very strong aﬃnity for the ﬁlm
and remained trapped in it even after extensive washing.15 In a
previous study, we have quantiﬁed the amount of adsorbed
BMP-2 that is trapped after thorough rinsing of the ﬁlm15 as a
function of the concentration of the BMP-2 solution used for
the loading and as a function of ﬁlm thickness. For an initial
BMP-2 concentration in solution of 100 μg/mL (used here for
its loading in the ﬁlm), this amount was estimated to be of 769
± 69 ng/cm2.15
For BMP-2 in hydrated ﬁlms, we noted at ﬁrst sight that the
absorbance was maximal at ∼1644 cm−1, showing similarities
with that of BMP-2 in solution at pH 3 (Figure 1A). However,
besides the ﬁve contributions already observed for BMP-2 in
solution, two new but very small contributions appeared at LW
(∼1615, 1628 cm−1) and HW (∼1691 cm−1) for BMP-2 in
ﬁlms, as compared to BMP-2 in solution (Figure 1). They can
unambiguously be attributed to intermolecular β-sheet
structures,30 which may result from either protein−protein
Figure 2. FTIR spectrum (A) and second derivative of the spectrum
(A′) of (PLL/HA)12 ﬁlm in hydrated and dry states: hydrated ﬁlm in
D2O (thick black line); hydrated ﬁlm in H2O (thick gray line); dry ﬁlm
(thin line). For the sake of comparison, the spectrum of the dry ﬁlm
was multiplied by 2.
Table 2. Position of the Main Peak of the Amide I Band for
PLL/HA Films Built in HEPES-NaCl in D2O, H2O, and after
Drying a Film Built in H2O
D2O H2O dry
amide I main peak 1638 1644 1656
COO− 1607 1600 1612
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interactions or from protein−polyelectrolyte interactions. All
the other peak positions present in the second derivatives were
close to those previously observed for the protein in solution.
We also performed control experiments to ensure that the
contribution of the ﬁlm to the BMP-2 spectrum was negligible.
To this end, the ﬁlm was subjected to the same sequence of
dipping as for BMP-2, except that BMP-2 was not added
(Figure SI2). A very small decrease in the 1600−1700 cm−1
region of 0.001 absorbance units, which is 25 times smaller than
the BMP-2 signal measured in the amide I band region (Figure
3A). Indeed, a positive absorbance was measured for BMP-2 in
the amide I band region.
The deconvolution of the spectrum (Table 1) led to the
most consistent results so far considering seven peaks. BMP-2
in hydrated ﬁlms mostly formed intramolecular β-sheets (36%),
unordered structures (31%), α-helix (18%), β-turn (11%), and
only a very minor fraction of intermolecular β-sheets (3%).
Indeed, the percentages of the diﬀerent types of secondary
structures diﬀered by only few percent from those of BMP-2 in
solution at pH 3. Thus, although BMP-2 was physically
conﬁned in the ﬁlm, its structure remained close to the one it
had in solution at pH 3.
At ﬁrst glance, the spectrum of BMP-2 trapped in a dry ﬁlm
(Figure 3B) was diﬀerent when compared to all other
conditions (BMP-2 in hydrated ﬁlm or in solution at diﬀerent
pHs). The maximum of the spectrum was shifted to a higher
wavenumber at 1652 cm−1. This shift of ∼8 cm−1 is reminiscent
of the shift observed for PLL/HA ﬁlms built in the HEPES-
Nacl buﬀer (in H2O) and dried (Figure 2). It may thus be due
to the diﬀerent experimental conditions used, notably, (i)
BMP-2 loading in water and not in D2O, which was used for
the in situ experiments in hydrated ﬁlms and (ii) drying of the
BMP-2 loaded ﬁlm, which restricts the mobility of the
polymeric and polypeptidic chains. Furthermore, the two
minima previously observed at 1670 and 1680 cm−1 were
replaced by a single but more pronounced minimum at 1677
cm−1, which renders the distinction between β-turn and
intramolecular β-sheets more diﬃcult. By considering the
systematic shift in the peak positions and by still considering
seven contributions, which gave the best ﬁts, we found that
BMP-2 in dry ﬁlms formed unordered structures (34%),
intramolecular β-sheets (26%), α-helix (21%), β-turn (16%),
and intermolecular β-sheets (3%). The most important
diﬀerences with BMP-2 in hydrated ﬁlms arose from the
decrease in intramolecular β-sheets and the concomitant
increase in unordered and β-turn structures.
Thus, FTIR revealed the predominance of β-sheets and
unordered structures on BMP-2 trapped in hydrated ﬁlms and
in dry ﬁlms as well. The fraction of intramolecular β-sheets
decreased from 42 to 51% for BMP-2 in solution to 25−36%
for BMP-2 in ﬁlms, the strongest decrease being observed for
BMP-2 in dry ﬁlms. The % of unordered structures in trapped
BMP-2 was higher (31−34%) for BMP-2 in ﬁlms as compared
to its solution counterpart (24−27%). The presence of α-helix
was also conﬁrmed, with an overall percentage of 16−24%.
Bioactivity of “Matrix-Bound” BMP-2 in Dry Films. An
important question is whether the bioactivity of matrix-bound
BMP-2 was maintained in dry ﬁlms, as we already know from
our previous studies that BMP-2 loaded in hydrated ﬁlms is
bioactive.15 In order to assess the bioactivity of BMP-2, we
chose C2C12 myoblast cells as a working model. These cells
constitute an acknowledged in vitro model system to study the
ability of BMPs to alter cell lineage from the myogenic to the
osteogenic phenotype,42 as BMP-2 induced the expression of
ALP. In a previous study, we have already demonstrated that
BMP-2 presented in a matrix-bound manner from hydrated
PLL/HA ﬁlms induced osteoblastic diﬀerentiation of C2C12
myoblasts.15 Here, the bioactivity of the ﬁlms was tested either
right after their preparation, i.e., in hydrated state, or after
drying of the ﬁlm for a short period (2 h) or after storage of the
ﬁlm in dry conditions for one month. First, we veriﬁed by FTIR
that the ﬁlms could be stored in the dry state for this time
period (Supporting Information Figure SI3). Only very minor
changes of less than 6% were noticed in the FTIR spectra,
especially in the COO− peak region and in the amide I band.
The ALP test was performed on C2C12 myoblasts after 3 days
of contact with the BMP-2 loaded ﬁlms (Figure 4). A control
value for the bioactivity of BMP-2 in solution (i.e., added to the
cell culture medium for 3 days) was also obtained in conditions
Figure 3. FTIR spectra and second derivative of BMP-2 trapped in cross-linked (PLL/HA)12 ﬁlms (A,A′) in a HEPES-NaCl buﬀer at pH 7.4
(hydrated ﬁlm) and (B,B′) after drying the ﬁlm (black: experimental spectrum; gray: ﬁtted spectrum).
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where the bioactivity has reached a plateau value15 (ie for a
BMP-2 concentration of 200 ng/mL).
Very interestingly, the BMP-2 loaded PLL/HA ﬁlms dried
for 2 h or dried and stored for 1 month retained a full activity,
similar to that of hydrated ﬁlms and to the plateau value
obtained for BMP-2 in solution. It is diﬃcult to precisely
quantify the fraction of BMP-2 that is bioactive in the hydrated
ﬁlm, which remained bioactive after drying of the ﬁlm.
However, a rough estimate can be made, considering the fact
that the ALP response is proportional to the amount of BMP-2
loaded in the ﬁlms15 and that a plateau value in the ALP signal
was observed for a BMP-2 concentration in the ﬁlm of ∼400
ng/cm2.15 As the eﬀective BMP-2 loaded concentration in the
ﬁlm was previously determined to be ∼770 ng/cm2 in our
experimental conditions,15 one can infer that at least 52% of
BMP-2 was bioactive. Thus, although there was a slight increase
in unordered structures upon drying of the BMP-2 loaded ﬁlm,
the overall activity of the protein was still very high after
rehydration of the ﬁlm. The presence of a large number of H-
bond in the (PLL/HA) ﬁlms40 and a large number of water
molecules around HA, even in the dry state,43 are probably
playing an important role in this process. Importantly, the
protein is trapped in the ﬁlm, but the structure of the ﬁlm
allowed it to retain a large fraction of intramolecular β-sheets
and to maintain its central α-helix. In analogy to sugars that are
widely used as stabilizing agents during drying of proteins,44 the
biopolymeric ﬁlm plays the role of stabilizer, or protective
carrier, for the protein.
In conclusion, BMP-2 trapped in hydrated and dry PLL/HA
ﬁlms retained its overall secondary structure, but an increase in
unordered structures and a decrease of β sheets was noted as
compared to BMP-2 in solution.
Importantly, the bioactivity of the dry BMP-2 loaded ﬁlms
remained at a similar level to that of hydrated ﬁlms, which
conﬁrmed the protective role of the ﬁlm in the stabilization of
the BMP-2 structural elements. These results appear highly
promising for future applications of these ﬁlms as coatings of
biomedical materials, to sequester proteins and to deliver them
locally, while preserving their bioactivity and secondary
structure. It would be interesting to investigate whether similar
mechanisms may take place for other types of growth factors
that have been successfully adsorbed on PEMs ﬁlms and whose
bioactivity was proved.45
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